A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2002
08/22/2002	US20020114791 Dehydration; freeze-drying; removing alcohol (sterol or cholesterol); loading with oligosaccharides to preserve; storage stability
08/22/2002	US20020114782 Stabilized interferon compositions
08/22/2002	US20020114780 Methods of increasing distribution of therapeutic agents
08/22/2002	US20020114778 Comprises ethylene oxide-propylene oxide block copolymer providing viscosity and hydroxypropyl methylcellulose improving durability, for moisturizing and lubricating eye drops containing opthalmic drugs
08/22/2002	US20020114775 Crosslinking agents and methods of use
08/22/2002	US20020114763 Inorganic materials for radioactive drug delivery
08/22/2002	DE10055857A1 Neue pharmazeutische Depotformulierung New pharmaceutical depot formulation
08/22/2002	CA2666611A1 Novel succinate salt of o-desmethyl-venlafaxine
08/22/2002	CA2438707A1 Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
08/22/2002	CA2438641A1 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
08/22/2002	CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002	CA2437890A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth
08/22/2002	CA2437864A1 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
08/22/2002	CA2437823A1 Acrochordon alleviation
08/22/2002	CA2437768A1 Targetted anti-tumor drug delivery systems
08/22/2002	CA2437731A1 A medicinal composition and use comprising turmeric extract for smoke detoxification
08/22/2002	CA2437578A1 Carotenoid-loaded liposomes
08/22/2002	CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors
08/22/2002	CA2434976A1 Medicament formulation containing a muscarinic agonist
08/22/2002	CA2434835A1 Novel modified released formulation
08/22/2002	CA2434641A1 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
08/22/2002	CA2434542A1 Novel modified release formulation
08/21/2002	EP1232758A1 Polynucleotide formulated for improved intracellular transfer
08/21/2002	EP1232753A1 Protein solution preparation and method of stabilizing the same
08/21/2002	EP1232752A1 Helium-oxygen mixture with therapeutic application
08/21/2002	EP1232746A1 Pharmaceutical composition comprising xanthan gum
08/21/2002	EP1232262A2 Recombinant gelatin in vaccines
08/21/2002	EP1232257A2 Modular transport systems for molecular substances and production and use thereof
08/21/2002	EP1232254A1 Process for the production of a reversibly inactive acidified plasmin composition
08/21/2002	EP1232252A1 Reversibly inactivated acidified plasmin
08/21/2002	EP1232251A1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
08/21/2002	EP1232246A1 A human normal counterpart of cd4+ cd56+ cutaneous neoplasm
08/21/2002	EP1232188A1 Cyclodextrins monosubstituted to persubstituted by fluoroalkyl groups, preparation and use thereof
08/21/2002	EP1232187A1 Potentiation of inclusion complex formation of cyclodextrin derivatives
08/21/2002	EP1232182A2 Animal collagens and gelatins
08/21/2002	EP1232181A2 Recombinant gelatins
08/21/2002	EP1232165A1 Phosphorus-containing dendrimers as transfection agents
08/21/2002	EP1232159A1 Beta-amyloid peptide inhibitors
08/21/2002	EP1232146A1 4-(4'-hydroxyphenyl)amino-6,7-dimethoxyquinazoline to prevent development of colorectal cancer
08/21/2002	EP1232100A1 Injection-moulded water-soluble container
08/21/2002	EP1231948A1 A propellant free spray-on skin patch composition for improving wound healing and for drug administration
08/21/2002	EP1231944A2 Targeted delivery of therapeutic and diagnostic moieties
08/21/2002	EP1231943A1 Interferon gamma conjugates
08/21/2002	EP1231942A1 Cobalamin conjugates useful as imaging agents and as antitumor agents
08/21/2002	EP1231941A1 Tablets comprising micro-organisms and method for preparation of the tablets
08/21/2002	EP1231940A1 Stable amorphous amifostine composition, and preparation thereof
08/21/2002	EP1231933A1 An aqueous solution formulation of alpha-interferon
08/21/2002	EP1231926A2 New complex, and methods for its production and use
08/21/2002	EP1231918A2 Novel composition based on a thiazolidinedione and metformin and use
08/21/2002	EP1231917A2 Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
08/21/2002	EP1231915A1 Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
08/21/2002	EP1231914A2 Nordihydroguaiaretic derivatives for use in treatment of tumors
08/21/2002	EP1231911A1 Directly compressible, ultra fine acetaminophen compositions and process for producing same
08/21/2002	EP1231909A2 Use of ubiquinone q10 for the local treatment and prevention of post-surgical ophthalmologic pathologies
08/21/2002	EP1231907A2 Dextrose and insulin fluid formulation for intravenous infusion
08/21/2002	EP1231905A2 Responsive polymeric hollow particles
08/21/2002	EP1231904A2 A method of microencapsulation
08/21/2002	EP1231903A2 Coating of tablet cores
08/21/2002	EP1231902A1 Film coating method for tablets
08/21/2002	EP1231901A1 Edible coating composition
08/21/2002	EP1231898A2 Apparatus and method for preparing microparticles
08/21/2002	EP1231897A2 Drug preparations
08/21/2002	EP1231894A1 Pharmaceutical formulations of salmeterol
08/21/2002	EP1231887A2 Method and composition for the treatment of scars
08/21/2002	EP1231877A1 Transdermal administration of huperzine
08/21/2002	EP1071330B1 Stabilization of isothiazolone
08/21/2002	EP0804456B1 Peptide nucleic acid conjugates
08/21/2002	EP0759757B1 Oral liquid alendronate formulations
08/21/2002	EP0644771B1 Erythropoietin drug delivery system
08/21/2002	EP0642580B1 Hepatocyte growth factor variants
08/21/2002	CN1365395A Tenascin-C nucleic acid liqands
08/21/2002	CN1365365A Process for preparing a charcoal-GM1 complex
08/21/2002	CN1365293A Agents promoting the formation of skin basement, agents promoting the formation of artificial skin and process for producing artificial skin
08/21/2002	CN1365288A Method for detecting and killing epithelial cancer cells
08/21/2002	CN1365282A Beta-carboline pharmaceutical compositions
08/21/2002	CN1365279A Preparations for reducing oxygen consumption during physical efforts
08/21/2002	CN1365274A Porous drug matrices and methods of manufacture thereof
08/21/2002	CN1365273A Percutaneous administration preparations
08/21/2002	CN1364645A Polycaprolactone-brufen composition and its preparation method and use
08/21/2002	CN1364458A Controlled release hydroxy-ketone
08/21/2002	CN1089249C Biocompactible somatotropin solutions
08/21/2002	CN1089236C Medicinal composition for preventing and curing hypokalemia
08/21/2002	CN1089233C 药物组合物 The pharmaceutical composition of
08/20/2002	US6437092 Administering polypeptide with lysine residue derivatized with maleimidopropionic acid; analgesics; narcotic abuse withdrawal
08/20/2002	US6437068 Thickener for cosmetic, drugs
08/20/2002	US6437025 Poly(ethylene glycol) derivatives with proximal reactive groups
08/20/2002	US6437009 Low foam n-alkyltartarimide and n-alkylmalimide wetting agents
08/20/2002	US6437006 Pharmaceutical carrier formulation
08/20/2002	US6437000 Controlled release oral dosage for suitable for oral administration
08/20/2002	US6436950 Effective for the amelioration of erectile dysfunction in a mammal without causing substantial intolerable adverse side effects; sodium metabisulfite, ascorbic acid, or sodium ascorbate reducing agent
08/20/2002	US6436935 Paste with polyacrylic acid
08/20/2002	US6436931 Cytotoxic agents comprising taxanes and their therapeutic use
08/20/2002	US6436912 Drug complex comprising carboxy(c.sub.1-4)alkyldextran polyalcohol and residue of drug compound bound to each other with spacer comprising amino acid or spacer comprising peptide-bonded 2 to 8 amino acids
08/20/2002	US6436905 Lipid-containing compositions and uses thereof
08/20/2002	US6436902 Therapeutic preparations for inhalation
08/20/2002	US6436901 Composition comprising hirudin, potassium phosphate and sugar, prepared by forming isotonic solution of hirudin, dipotassium hydrogen phosphate, and selected sugar at specified hirudin concentration and freeze drying solution
08/20/2002	US6436899 Nutritional intervention composition for enhancing and extending satiety
08/20/2002	US6436897 Pharmaceutical formulations for IGF/IGFBP
08/20/2002	US6436691 Chemical compounds
08/20/2002	US6436682 Isolated substantially purified gaussia, renilla mulleri or pleuromamma luciferase protein encoded by specified nucleotide sequences

1 ... 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 ... 1712